File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Case Report: Insulinoma Co-Existing With Type 2 Diabetes – Advantages and Challenges of Treatment With Endoscopic Ultrasound-Guided Radiofrequency Ablation

TitleCase Report: Insulinoma Co-Existing With Type 2 Diabetes – Advantages and Challenges of Treatment With Endoscopic Ultrasound-Guided Radiofrequency Ablation
Authors
Issue Date2022
Citation
Frontiers in Endocrinology, 2022, v. 13 How to Cite?
AbstractThe coexistence of insulinoma and type 2 diabetes is rare and the diagnostic process is often challenging. Continuous glucose monitoring system devices, which are more readily available nowadays, provide a useful tool for the diagnosis and evaluation of treatment response. Curative surgery is often the mainstay of treatment for insulinoma. Here, we report a Chinese patient with insulinoma diagnosed simultaneously with type 2 diabetes. His insulinoma was managed with endoscopic ultrasound guided-radiofrequency ablation (EUS-RFA) and the patient achieved complete resolution of hypoglycaemic episodes. The case illustrates that while EUS-RFA is an emerging non-invasive treatment modality for pancreatic lesions, limitations exist especially when histological confirmation is essential.
Persistent Identifierhttp://hdl.handle.net/10722/317835
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorChang, JYC-
dc.contributor.authorWoo, CSL-
dc.contributor.authorLui, TWD-
dc.contributor.authorFung, MMH-
dc.contributor.authorLee, ACH-
dc.contributor.authorLeung, EKH-
dc.contributor.authorWoo, YC-
dc.contributor.authorChow, WS-
dc.contributor.authorLam, KSL-
dc.contributor.authorTan, KCB-
dc.contributor.authorLee, CHP-
dc.date.accessioned2022-10-07T10:27:47Z-
dc.date.available2022-10-07T10:27:47Z-
dc.date.issued2022-
dc.identifier.citationFrontiers in Endocrinology, 2022, v. 13-
dc.identifier.urihttp://hdl.handle.net/10722/317835-
dc.description.abstractThe coexistence of insulinoma and type 2 diabetes is rare and the diagnostic process is often challenging. Continuous glucose monitoring system devices, which are more readily available nowadays, provide a useful tool for the diagnosis and evaluation of treatment response. Curative surgery is often the mainstay of treatment for insulinoma. Here, we report a Chinese patient with insulinoma diagnosed simultaneously with type 2 diabetes. His insulinoma was managed with endoscopic ultrasound guided-radiofrequency ablation (EUS-RFA) and the patient achieved complete resolution of hypoglycaemic episodes. The case illustrates that while EUS-RFA is an emerging non-invasive treatment modality for pancreatic lesions, limitations exist especially when histological confirmation is essential.-
dc.languageeng-
dc.relation.ispartofFrontiers in Endocrinology-
dc.titleCase Report: Insulinoma Co-Existing With Type 2 Diabetes – Advantages and Challenges of Treatment With Endoscopic Ultrasound-Guided Radiofrequency Ablation-
dc.typeArticle-
dc.identifier.emailLui, TWD: dtwlui@hku.hk-
dc.identifier.emailLam, KSL: ksllam@hku.hk-
dc.identifier.emailTan, KCB: kcbtan@hkucc.hku.hk-
dc.identifier.emailLee, CHP: pchlee@hku.hk-
dc.identifier.authorityLui, TWD=rp02803-
dc.identifier.authorityLam, KSL=rp00343-
dc.identifier.authorityTan, KCB=rp00402-
dc.identifier.authorityLee, CHP=rp02043-
dc.identifier.doi10.3389/fendo.2022.957369-
dc.identifier.hkuros337181-
dc.identifier.volume13-
dc.identifier.isiWOS:000837107900001-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats